Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of our study was to compare the effect of autologous stem cell therapy (SCT) and percutaneous transluminal angioplasty (PTA) on diabetic foot disease (DFD) in patients with critical limb ischemia (CLI).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cytotherapy

Title: Cytotherapy

ISSN (Electronic): 1477-2566

ISSN (Print): 1465-3249

Publication date (Electronic): Dec 2014

Volume: 16

Issue: 12

Affiliations

[1 ] Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: michal.dubsky@gmail.com.

[2 ] Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

[3 ] Institute of Experimental Medicine, Czech Academy of Science, Prague, Czech Republic.

[4 ] Diabetes Centre, Tameside Hospital NHS Foundation Trust and University of Manchester, Lancashire, United Kingdom.

Article

Publisher Item ID: S1465-3249(14)00742-7

DOI: 10.1016/j.jcyt.2014.08.010

PubMed ID: 25304666

SO-VID: 84088806-06ef-4197-bb6c-92304c45babf

History

Keywords: critical limb ischemia,percutaneous transluminal angioplasty,stem cell therapy

Data availability:

Keywords: critical limb ischemia, percutaneous transluminal angioplasty, stem cell therapy

Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia.

Read this article at

Abstract

Related collections

Orthopedics

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 13